other material
confidence high
sentiment positive
materiality 0.75
Clene raises $28M in registered direct offering from Boxer, Coastlands, Vivo Capital
Clene Inc.
- Offering totals $28M in three tranches; initial $6.03M closed Jan 13, 2026 at $6.50/unit.
- Additional tranches: $6.7M Series A warrants contingent on PDUFA date, $15.6M Series B on FDA approval.
- Warrants exercise price adjustable based on stock price milestones; redeemable if in-the-money.
- Investors include Boxer Capital, Coastlands Capital, Vivo Capital; BTIG as sole placement agent.
- Proceeds expected to fund operations into early 2027, supporting NDA and potential CNM-Au8 commercialization in ALS.